Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Structure/Function Reg Burdens Companies With Potential Liability - Attorney

This article was originally published in The Tan Sheet

Executive Summary

FDA's structure/function claims final reg could make dietary supplement companies vulnerable to product liability lawsuits stemming from claims substantiation requirements and failure to disclose to consumers material information about the products, an industry attorney said at a joint CHPA/CRN briefing on the final rule Feb. 16.

You may also be interested in...



Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter

CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter

Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter

CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter

Mars CocoaVia Chocolate Bars Receive No Kudos In FDA Warning Letter

CocoaVia chocolate bars are adulterated "in that they contain a food additive, namely folic acid, which is unsafe within the meaning of section 409" of the FD&C Act, CFSAN Office of Compliance Director Joseph Baca tells Mars in a recent warning letter

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090894

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel